These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 1790403)

  • 1. A randomized trial of sodium fluoride as a treatment for postmenopausal osteoporosis.
    Kleerekoper M; Peterson EL; Nelson DA; Phillips E; Schork MA; Tilley BC; Parfitt AM
    Osteoporos Int; 1991 Jun; 1(3):155-61. PubMed ID: 1790403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of nonrandomized trials with slow-release sodium fluoride with a randomized placebo-controlled trial in postmenopausal osteoporosis.
    Pak CY; Adams-Huet B; Sakhaee K; Bell NH; Licata A; Johnston C; Rubin B; Bonnick S; Piziak V; Graham H; Ballard J; Berger R; Fears W; Breslau N; Rubin C
    J Bone Miner Res; 1996 Feb; 11(2):160-8. PubMed ID: 8822339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluoride salts are no better at preventing new vertebral fractures than calcium-vitamin D in postmenopausal osteoporosis: the FAVOStudy.
    Meunier PJ; Sebert JL; Reginster JY; Briancon D; Appelboom T; Netter P; Loeb G; Rouillon A; Barry S; Evreux JC; Avouac B; Marchandise X
    Osteoporos Int; 1998; 8(1):4-12. PubMed ID: 9692071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized trial of sodium fluoride (60 mg) +/- estrogen in postmenopausal osteoporotic vertebral fractures: increased vertebral fractures and peripheral bone loss with sodium fluoride; concurrent estrogen prevents peripheral loss, but not vertebral fractures.
    Gutteridge DH; Stewart GO; Prince RL; Price RI; Retallack RW; Dhaliwal SS; Stuckey BG; Drury P; Jones CE; Faulkner DL; Kent GN; Bhagat CI; Nicholson GC; Jamrozik K
    Osteoporos Int; 2002; 13(2):158-70. PubMed ID: 11908491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained-release sodium fluoride in the treatment of the elderly with established osteoporosis.
    Rubin CD; Pak CY; Adams-Huet B; Genant HK; Li J; Rao DS
    Arch Intern Med; 2001 Oct; 161(19):2325-33. PubMed ID: 11606148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sodium fluoride therapy of postmenopausal osteoporosis.
    Kleerekoper M; Mendlovic DB
    Endocr Rev; 1993 Jun; 14(3):312-23. PubMed ID: 8319597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluoride therapy of type I osteoporosis.
    Devogelaer JP; Nagant de Deuxchaisnes C
    Clin Rheumatol; 1995 Sep; 14 Suppl 3():26-31. PubMed ID: 8846658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of postmenopausal osteoporosis with slow-release sodium fluoride. Final report of a randomized controlled trial.
    Pak CY; Sakhaee K; Adams-Huet B; Piziak V; Peterson RD; Poindexter JR
    Ann Intern Med; 1995 Sep; 123(6):401-8. PubMed ID: 7639438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Slow-release sodium fluoride in the management of postmenopausal osteoporosis. A randomized controlled trial.
    Pak CY; Sakhaee K; Piziak V; Peterson RD; Breslau NA; Boyd P; Poindexter JR; Herzog J; Heard-Sakhaee A; Haynes S; Adams-Huet B; Reisch JS
    Ann Intern Med; 1994 Apr; 120(8):625-32. PubMed ID: 8135445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis.
    Riggs BL; Hodgson SF; O'Fallon WM; Chao EY; Wahner HW; Muhs JM; Cedel SL; Melton LJ
    N Engl J Med; 1990 Mar; 322(12):802-9. PubMed ID: 2407957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of sodium monofluorophosphate plus calcium on vertebral fracture rate in postmenopausal women with moderate osteoporosis. A randomized, controlled trial.
    Reginster JY; Meurmans L; Zegels B; Rovati LC; Minne HW; Giacovelli G; Taquet AN; Setnikar I; Collette J; Gosset C
    Ann Intern Med; 1998 Jul; 129(1):1-8. PubMed ID: 9652994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of vertebral osteoporosis with disodium monofluorophosphate: comparison with sodium fluoride.
    Delmas PD; Dupuis J; Duboeuf F; Chapuy MC; Meunier PJ
    J Bone Miner Res; 1990 Mar; 5 Suppl 1():S143-7. PubMed ID: 2339624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical trial of fluoride therapy in postmenopausal osteoporotic women: extended observations and additional analysis.
    Riggs BL; O'Fallon WM; Lane A; Hodgson SF; Wahner HW; Muhs J; Chao E; Melton LJ
    J Bone Miner Res; 1994 Feb; 9(2):265-75. PubMed ID: 8140940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclical etidronate versus sodium fluoride in established postmenopausal osteoporosis: a randomized 3 year trial.
    Guañabens N; Farrerons J; Perez-Edo L; Monegal A; Renau A; Carbonell J; Roca M; Torra M; Pavesi M
    Bone; 2000 Jul; 27(1):123-8. PubMed ID: 10865219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group.
    Harris ST; Watts NB; Genant HK; McKeever CD; Hangartner T; Keller M; Chesnut CH; Brown J; Eriksen EF; Hoseyni MS; Axelrod DW; Miller PD
    JAMA; 1999 Oct; 282(14):1344-52. PubMed ID: 10527181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clodronate reduces vertebral fracture risk in women with postmenopausal or secondary osteoporosis: results of a double-blind, placebo-controlled 3-year study.
    McCloskey E; Selby P; Davies M; Robinson J; Francis RM; Adams J; Kayan K; Beneton M; Jalava T; Pylkkänen L; Kenraali J; Aropuu S; Kanis JA
    J Bone Miner Res; 2004 May; 19(5):728-36. PubMed ID: 15068495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sodium fluoride treatment is a major protector against vertebral and nonvertebral fractures when compared with other common treatments of osteoporosis: a longitudinal, observational study.
    Farrerons J; Rodríguez de la Serna A; Guañabens N; Armadans L; López-Navidad A; Yoldi B; Renau A; Vaqué J
    Calcif Tissue Int; 1997 Mar; 60(3):250-4. PubMed ID: 9069161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of osteoporosis with human parathyroid peptide and observations on effect of sodium fluoride.
    Reeve J; Davies UM; Hesp R; McNally E; Katz D
    BMJ; 1990 Aug; 301(6747):314-8. PubMed ID: 2393738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluoride and bone: a second look. No use in osteoporosis.
    Prescrire Int; 1998 Aug; 7(36):110-1. PubMed ID: 10342949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis.
    Chesnut CH; Skag A; Christiansen C; Recker R; Stakkestad JA; Hoiseth A; Felsenberg D; Huss H; Gilbride J; Schimmer RC; Delmas PD;
    J Bone Miner Res; 2004 Aug; 19(8):1241-9. PubMed ID: 15231010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.